Pantoprazol Takeda 20 mg

Pantoprazol Takeda is a pharmaceutical product used to treat conditions such as acid reflux and stomach ulcers by reducing gastric acid production. The brand belongs to Takeda Pharmaceutical Company Limited, a global biopharmaceutical leader with a long history of innovation.

Originally developed by the German pharmaceutical company Nycomed (specifically under the brand names Protonix and Pantoloc), the product became part of Takeda's portfolio following its multi-billion dollar acquisition of Nycomed in 2011. While the brand has Japanese roots, the actual manufacture of these specific tablets often takes place at various global sites, including specialized facilities in Germany and Poland, to supply the European market.

In Denmark, the product is distributed and managed by Takeda Pharma A/S, the local subsidiary. The ultimate ownership remains with Takeda Pharmaceutical Company Limited, which is publicly traded on the Tokyo and New York stock exchanges and headquartered in Tokyo, Japan.